Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025 - Candlesense

TNYA Clinical trials

Tenaya Therapeutics Presents Interim Data from MyClimb™ Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025

Published August 31, 2025 at 02:15 PM

(NASDAQ:TNYA) Largest Noninterventional Natural History Study of People Under 18 with MYBPC3-associated HCM with More than 200 Participants